<p>(A) C2C12 cells were infected with either shRNA encoding for a non-target or LKB1 sequences and differentiated into myotubes before being transduced with either the 11R-WT or 11R-Sca peptides (40nM). LKB1, total AMPK (tAMPK), phospho- T<sup>172</sup> AMPK, total ACC (tACC), phospho S<sup>79</sup>-ACC and loading control GAPDH protein expression levels were determined using specific antibodies. Images are representative of 3 independent experiments. (B) Signal quantification from 3 experiments. Identical letters indicate values that are not statistically different from each other (P>0.05). (C) 3 months old male C57B6/J mice were euthanized and EDL muscles were rapidly removed and incubated for 30 min in oxygenated (95% O<sub>2</sub>, 5% C...
<p>(A) Phase contrast pictures of C2C12 cells transfected an siRNA directed against mouse LKB1 (LKB1...
<div><p>Fyn-deficient mice display increased AMP-activated Protein Kinase (AMPK) activity as a resul...
<p>Serum-starved HeLa cells (<b>A–C</b>) or L6 myotubes (<b>D–F</b>) were pre-treated ±1 µM STO-609 ...
<p>(A) C2C12 myotubes were transducted with either the 11R-LKB1-proline-rich domain (11R-WT) or the ...
<p>(A) <i>Tibialis anterior</i> of control mice was transfected with either with pcDNA-Flag-LKB1-WT ...
<p>Differentiated C2C12 cells (A) were transfected with LKB1 siRNA for 24 h. Two different fields of...
<p>A: Representative Western blot of AMPK α<sub>2</sub> in AMPK WT and KD muscles. The absence of a ...
<p>(a) Indicated agents were treated for 5 min and 5 µM concentration with or without 30 min pre-inc...
<p>(A) Differentiated L6 cells were treated with MES (0.1 ms, 1 V/cm, 55 pps) for 10 min. Cell lysat...
<p>(A) Glucose tolerance was analyzed in WT or DARP-/- mice treated with AICAR at the age of 24 week...
<p>Ncls treatment led to (A) increased phospho-AMPKα (pAMPKα), increased phospho-ACC2 (pACC2), and (...
Fyn-deficient mice display increased AMP-activated Protein Kinase (AMPK) activity as a result of Fyn...
<p>This is a representative blot from three individual experiments. The density of the bands were qu...
Aim—The Liver Kinase B1 (LKB1)/AMP-Activated Protein Kinase (AMPK) signaling pathway is a major regu...
Fyn-deficient mice display increased AMP-activated Protein Kinase (AMPK) activity as a result of Fyn...
<p>(A) Phase contrast pictures of C2C12 cells transfected an siRNA directed against mouse LKB1 (LKB1...
<div><p>Fyn-deficient mice display increased AMP-activated Protein Kinase (AMPK) activity as a resul...
<p>Serum-starved HeLa cells (<b>A–C</b>) or L6 myotubes (<b>D–F</b>) were pre-treated ±1 µM STO-609 ...
<p>(A) C2C12 myotubes were transducted with either the 11R-LKB1-proline-rich domain (11R-WT) or the ...
<p>(A) <i>Tibialis anterior</i> of control mice was transfected with either with pcDNA-Flag-LKB1-WT ...
<p>Differentiated C2C12 cells (A) were transfected with LKB1 siRNA for 24 h. Two different fields of...
<p>A: Representative Western blot of AMPK α<sub>2</sub> in AMPK WT and KD muscles. The absence of a ...
<p>(a) Indicated agents were treated for 5 min and 5 µM concentration with or without 30 min pre-inc...
<p>(A) Differentiated L6 cells were treated with MES (0.1 ms, 1 V/cm, 55 pps) for 10 min. Cell lysat...
<p>(A) Glucose tolerance was analyzed in WT or DARP-/- mice treated with AICAR at the age of 24 week...
<p>Ncls treatment led to (A) increased phospho-AMPKα (pAMPKα), increased phospho-ACC2 (pACC2), and (...
Fyn-deficient mice display increased AMP-activated Protein Kinase (AMPK) activity as a result of Fyn...
<p>This is a representative blot from three individual experiments. The density of the bands were qu...
Aim—The Liver Kinase B1 (LKB1)/AMP-Activated Protein Kinase (AMPK) signaling pathway is a major regu...
Fyn-deficient mice display increased AMP-activated Protein Kinase (AMPK) activity as a result of Fyn...
<p>(A) Phase contrast pictures of C2C12 cells transfected an siRNA directed against mouse LKB1 (LKB1...
<div><p>Fyn-deficient mice display increased AMP-activated Protein Kinase (AMPK) activity as a resul...
<p>Serum-starved HeLa cells (<b>A–C</b>) or L6 myotubes (<b>D–F</b>) were pre-treated ±1 µM STO-609 ...